| MolName | 2-[(2-boronophenyl)methoxy]-5-[(E)-1-[4-[(2-boronophenyl)methoxy]-3-carboxyphenyl]-4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]but-1-enyl]-3-chlorobenzoic acid |
| MolecularFormula | C59H75O10B2Cl |
| Smiles | CC(C)CCCC(C)C(CC1)C(C)(CC2)C1C(CC1)C2C2(C)C1CC(CC/C=C(\c(cc1)cc(C(O)=O)c1OCc1c(B(O)O)cccc1)/c(cc1C(O)=O)cc(Cl)c1OCc1c(B(O)O)cccc1)CC2 |
| InChI | InChI=1S/C59H75B2ClO10/c1-36(2)12-10-13-37(3)48-23-24-49-45-22-21-43-30-38(26-28-58(43,4)50(45)27-29-59(48,49)5)14-11-17-44(39-20-25-54(46(31-39)56(63)64)71-34-40-15-6-8-18-51(40)60(67)68)42-32-47(57(65)66)55(53(62)33-42)72-35-41-16-7-9-19-52(41)61(69)70/ |
| InChIK | IBZZSRSBGJVJNY-UHFFFAOYSA-N |
| TotalMolweight | 1001.31 |
| Molweight | 1001.31 |
| MonoisotopicMass | 1000.52349 |
| CLogP | 13.358 |
| CLogS | -8.349 |
| H Acceptors | 10 |
| H Donors | 6 |
| TotalSurfaceArea | 763.75 |
| Relative PSA | 0.16325 |
| PolarSurfaceArea | 173.98 |
| Druglikeness | -14.571 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | unwanted atom |
| Shape Index | 0.40278 |
| Fragments | 1 |
| Non HAtoms | 72 |
| NonCHAtoms | 13 |
| Electronegative Atoms | 11 |
| StereoCenters | 9 |
| Rotatable Bond | 20 |
| Rings Closures | 8 |
| Small Rings | 8 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 39 |
| Symmetricatoms | 3 |
| AcidicOxygens | 2 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - 2-[(2-boronophenyl)methoxy]-5-[(E)-1-[4-[(2-boronophenyl)methoxy]-3-carboxyphenyl]-4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]but-1-enyl]-3-chlorobenzoic acid | 2 - 2-[(2-boronophenyl)methoxy]-5-[(E)-1-[4-[(2-boronophenyl)methoxy]-3-carboxyphenyl]-4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]but-1-enyl]-3-chlorobenzoic acid